Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02318342 · ClinicalTrials.gov registry record · NA
Assessment of TRanscathetEr and Surgical Aortic BiOprosthetic Valve Thrombosis and Its TrEatment With Anticoagulation
A NA study of Prosthetic Valve Thrombosis, sponsored by Cedars-Sinai Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 3,000
- Enrollment target
- 1
- Study location
NCT02318342 is a NA study of Prosthetic Valve Thrombosis that is actively recruiting participants, run by Cedars-Sinai Medical Center. The registered enrollment target is 3,000 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02318342, a NA study of Prosthetic Valve Thrombosis, is actively recruiting participants, sponsored by Cedars-Sinai Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 3,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective study designed to evaluate the structural and functional integrity of transcatheter or surgical bioprosthetic valves with multimodality imaging. The study further aims to confirm resolution of the early bioprosthetic valve thrombotic changes with anticoagulation.
Conditions Studied
Interventions
- DRUG Warfarin
Study Locations (1)
California
- Cedars-Sinai Medical Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2014-12 |
| Est. Completion | 2027-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02318342
The ClinicalTrials.gov registry entry for NCT02318342 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 3,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Prosthetic Valve Thrombosis appearing as the primary indexed condition, and to 1 intervention - of which Warfarin is the first listed.
NCT02318342 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02318342 about?
NCT02318342 is a clinical study titled "Assessment of TRanscathetEr and Surgical Aortic BiOprosthetic Valve Thrombosis and Its TrEatment With Anticoagulation". This is a prospective study designed to evaluate the structural and functional integrity of transcatheter or surgical bioprosthetic valves with multimodality imaging. The study further aims to confirm resolution of the early bioprosthetic valve thrombotic changes with anticoagulation.
What is the current status of trial NCT02318342?
This trial is currently recruiting. It is a NA study. The enrollment target is 3,000 participants. The study started on 2014-12. Estimated completion is 2027-12.
What conditions does trial NCT02318342 study?
This clinical trial studies the following conditions: Prosthetic Valve Thrombosis.
What interventions are being tested in trial NCT02318342?
The interventions under investigation include: Warfarin (DRUG).
Who is sponsoring clinical trial NCT02318342?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02318342 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.